1-3 of 3
Florian Heidel, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Ruxolitinib-Response Feature on Outcome in Myelofibrosis: A Multicentre Study on 356 Patients

Giulia Benevolo, MD, Giuseppe A Palumbo, MD, Massimiliano Bonifacio, MD, Mario Tiribelli, MD, Maura Nicolosi, MD, Andrea Evangelista, Bruno Martino, Elisabetta Abruzzese, MD, Mariella D'adda, Nicola Polverelli, MD, Micaela Bergamaschi, MD, Alessandra Tieghi, MD, Francesco Cavazzini, MD, Adalberto Ibatici, MD, Monica Crugnola, MD, Costanza Bosi, MD, Roberto Latagliata, Lucia Catani, MD, Franco Aversa, MD, Francesco Di Raimondo, MD, Umberto Vitolo, MD, Roberto Massimo Lemoli, MD, Renato Fanin, MD, Francesco Merli, Antonio Cuneo, MD, Michele Cavo, MD, Massimo Breccia, MD PhD, Nicola Vianelli, MD, Florian Heidel, MD, Francesca Palandri, PhD MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1639.
https://doi.org/10.1182/blood.V130.Suppl_1.1639.1639
Published: 2017
Journal Articles

The JAK2 Kinase Inhibitor LS104 Induces Growth-Arrest and Apoptosis in JAK2V617F Positive Cells.

Daniel B. Lipka, MD, Linda S. Hoffmann, MSc, Florian Heidel, MD, Boyka Markova, PhD, Stefan Kasper, MD, Frank Breitenbuecher, PhD, Thomas Kindler, MD, Ross Levine, MD, Joseph Elliot, PhD, Christoph Huber, MD, Thomas Fischer, MD
Journal: Blood
Blood (2007) 110 (11): 3544.
https://doi.org/10.1182/blood.V110.11.3544.3544
Published: 2007
Journal Articles

LS104, a Novel Kinase Inhibitor, Induces Apoptosis, Synergizes with Cytostatic Drugs and Is Targeting the Receptor Tyrosine Kinase FLT3.

Stefan Kasper, Thomas Kindler, MD, Florian Heidel, MD, Frank Breitenbuecher, PhD, Yvette Hoehn, MD, Daniel Lipka, Helmut Thomas, PhD, Christoph Huber, MD, Thomas Fischer, MD
Journal: Blood
Blood (2005) 106 (11): 3362.
https://doi.org/10.1182/blood.V106.11.3362.3362
Published: 2005